Our current state
h/t @MichaelGIsonMD pic.twitter.com/Y9Pe7Xp0aC— Kavita Patel M.D. (@kavitapmd) January 9, 2022
Some states are opening mass vaccination sites because of the #omicron surge. The US is averaging ~650,000 new *known* cases a day, far more than last winter’s peak https://t.co/LFvr1CKxra
— delthia ricks
(@DelthiaRicks) January 9, 2022
If the U.S.'s daily death toll from COVID stays where it is — doesn't even increase — we'll hit 1 million Americans dead in 100 days.
April 19th.https://t.co/Mm5fP83dfh pic.twitter.com/5oroiQsJrY
— Eric Umansky (@ericuman) January 10, 2022
Omicron is hitting the US much harder than the UK (or South Africa) in large part because we have significantly fewer double-vaxx'd adults and significantly fewer boosted seniors.
(data via @OurWorldInData and @jburnmurdoch) pic.twitter.com/rpWCsDWCyF
— Derek Thompson (@DKThomp) January 9, 2022
WATCH: "We will never get to 70, 80, or 90% of the population vaccinated without a mandate," @ZekeEmanuel says. #MTP
"And for the Supreme Court to take that away in the midst of an emergency seems to me to be very wrong." pic.twitter.com/3T3oCKWBbz
— Meet the Press (@MeetThePress) January 9, 2022
======
We’ve now set the stage to manufacture >1 billion doses in the coming months for LMICs. But this is happening mostly without the help of the US Govt or other G7 nations. Right now the G7 has no plan. We can help.
— Prof Peter Hotez MD PhD (@PeterHotez) January 9, 2022
called it. (It was a very obvious call.) https://t.co/MNvx8zu4ix
— James Palmer (@BeijingPalmer) January 10, 2022
Tianjin, a major Chinese city near Beijing, has placed its 14 million residents on partial lockdown after 40 children and adults tested positive for COVID-19, including at least two with the omicron variant. https://t.co/2GvVJy9Kob
— The Associated Press (@AP) January 10, 2022
Actually Local authorities want anyone who may have symptoms or has reason to suspect they are infected to get tested and treated at facilities controlled by the government. They don’t want patients to be able to hide from them through self-testing and treatment). https://t.co/yzpdX1JQu2
— Dali L. Yang (@Dali_Yang) January 9, 2022
Healthcare and front-line workers along with people above age 60 with health problems are lining up at vaccination centers across India to receive booster shots as infections linked to the omicron variant surge. https://t.co/gkbDfyqk7M
— The Associated Press (@AP) January 10, 2022
India's new COVID-19 cases surge to 179,723 https://t.co/JCgO9Nbwk0 pic.twitter.com/xNNt2Mj49x
— Reuters (@Reuters) January 10, 2022
Philippines logs record 33,169 daily COVID-19 infections https://t.co/Mn4Sz5Yn1C pic.twitter.com/ecE6BSXODF
— Reuters (@Reuters) January 10, 2022
COVID-19 infections in Australia surpassed 1 million, more than half in the past week alone, throwing a strain on hospitals and supply chains. Prime Minister Scott Morrison said the country must 'push through' the fast-moving Omicron outbreak https://t.co/6wyb0anOu0 pic.twitter.com/lasPjtaBtf
— Reuters (@Reuters) January 10, 2022
With peak yet to come, Europe's healthcare creaks under Omicron's rapid spread https://t.co/PhakVQnPD8 pic.twitter.com/6dHthRXkKl
— Reuters (@Reuters) January 10, 2022
Hungary's daily COVID-19 cases could hit new peak exceeding 13,000 – minister https://t.co/ceBLDPdK9z pic.twitter.com/HIl1xO9FMF
— Reuters (@Reuters) January 10, 2022
Germany's ruling parties say plans to make coronavirus vaccinations compulsory may take months to pass in parliament. Some leaders previously had hoped a mandate could take effect as early as February. https://t.co/Fg6I0OXDNA
— AP Europe (@AP_Europe) January 9, 2022
Britain puts private health firms on high alert as Omicron threatens NHS https://t.co/EdVSkMafEJ pic.twitter.com/niF12LYSXd
— Reuters (@Reuters) January 10, 2022
United Kingdom:
Avacta pauses sales of COVID-19 antigen test to boost Omicron sensitivity https://t.co/AeSVnltQ13 pic.twitter.com/zrERNGVDJ2
— Reuters (@Reuters) January 10, 2022
Brazil has 24,382 cases of coronavirus in 24 hours, 44 COVID-19 deaths -ministry https://t.co/tA6OY66hBg pic.twitter.com/YsqV5vVAiY
— Reuters (@Reuters) January 10, 2022
Moderna donates 2.7 million vaccine doses to Mexico as COVID cases surge https://t.co/0qxEYDAj4b pic.twitter.com/yCuyYenhgp
— The Hill (@thehill) January 9, 2022
#Omicron variant’s rapid spread in underscores a political reality: There are two pandemics in Canada
— one for the rich and one for the poor via @globeandmail @AmitAryaMD #COVID19 #cdnpoli #cdnhealth #sdoh https://t.co/bpfsc4wCA5 pic.twitter.com/WLOnwWMfCg
— André Picard (@picardonhealth) January 8, 2022
======
Wow, this blew up! Thanks for paying it forward, lovely humans.
Here's some great info on how to safely reuse these masks:https://t.co/q6mY0h3rTN
— laurie allee (@laurieallee) January 10, 2022
Is so-called "deltacron" a recombination event or a contaminated sample? This virologist says evidence so far points to contamination ↓ https://t.co/SG2mhtSRac
— delthia ricks
If a host cell contains two different coronavirus genomes for example #Delta and #Omicron at the same time, the enzyme can repeatedly jump from one to the other, combining different elements of each genome to create a hybrid virus.
— BK Titanji #ILookLikeAScientist (@Boghuma) January 9, 2022
The best thing we can do besides worrying about it and coining variant names that sound like a "Transformers" villain, is ensuring that vaccines are available to everyone and combining vaccination with other strategies that give the virus fewer opportunities to spread.
— BK Titanji #ILookLikeAScientist (@Boghuma) January 9, 2022
Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners https://t.co/x8Sfc72CqW pic.twitter.com/spFLVUmhQu
— Reuters (@Reuters) January 10, 2022
… The DARPin (Designed Ankyrin Repeat Protein) antiviral therapeutic candidate met the primary endpoint of viral load reduction over eight days in a study in acute COVID-19 ambulatory patients comparing single intravenous doses of ensovibep versus placebo, the two companies said in a statement.
The two secondary endpoints also showed a clinically meaningful benefit compared with a placebo, the partners said.
Novartis will first seek the approval from the U.S. Food and Drug Administration (FDA), where it is applying for an Emergency Use Authorization (EUA).
DARPins offer a differentiated approach to treating COVID-19 through a single molecule that can engage up to three parts of the SARS-CoV-2 virus simultaneously to neutralize the virus through multiple mechanisms, Molecular Partners said on its website…
======
Because at this point in the pandemic
the shortage is not ventilators or ICU beds
The shortage is in doctors, nurses, respiratory therapists, and other healthcare workers
So field hospitals won't help
And we can't conjure up more doctors and nurses in short order https://t.co/LPzxz3Yw8V
— Ashish K. Jha, MD, MPH (@ashishkjha) January 8, 2022
“I think many people now come to work sick … because they feel they have no other choice,” Millions of U.S. workers who don't get paid sick days are having to choose between their health and their paycheck as the omicron variant rages. https://t.co/ktTD7GNhu8
— The Associated Press (@AP) January 9, 2022
Meanwhile, in the real world https://t.co/q3yIzxmyEe
— Rai-Ben Franklin (@raibenfranklin) January 8, 2022
If I had to name the most influential factor in making the pandemic worse, it would be this.
Not only did their media war entrench their troops, it's polluted the discourse so the plague bros can declare the pandemic over and others can just ignore it. https://t.co/2ecd6aL4UO
— Cheryl Rofer (@CherylRofer) January 9, 2022
The post COVID-19 Coronavirus Updates: Sunday / Monday, Jan. 9-10 appeared first on Balloon Juice.